Netarsudil (AR-13324) ophthalmic solution

netarsudil · Aerie Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Netarsudil (AR-13324) ophthalmic solution, covering 2018-04-06 to 2018-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]